Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight

On Thursday, Eli Lilly and Co. (NYSE:LLY) revealed topline results from the novel TOGETHER-PsA open-label Phase 3b trial ...
Fierce Pharma

Lilly touts promise of Zepbound-Taltz combo in patients with obesity and psoriatic arthritis

In an open-label phase 3b trial, the co-administration of Lilly’s IL-17A antagonist Taltz (ixekizumab) and dual GIP/GLP-1 ...
Medical Dialogues

Ixekizumab and Tirzepatide combo Improves PsA Control and Weight Loss, suggests study

The TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis ...
Post Bulletin

After last year's bitter ending, Logan Pearson is motivated to deliver a special season

The Chatfield sophomore thought he reached the Class 1A, 114-pound state finals last year, but was disqualified from his ...

Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the novel TOGETHER-PsA open-label Phase 3b ...
Arizona Daily Star

Jury weighs death penalty in dual killing

Shad Armstrong in February 1998 dug a huge grave, turned garbage bags and sheets into dropcloths and then used a shotgun to kill his sister and her fiancé. What defense attorneys and prosecutors don't ...